Search

Search Results
Results 431 - 440 of 967 for allergy
  • Clopidogrel Winthrop Plus Aspirin
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop Plus Aspirin intended for persons living in Australia.
  • APX-Clopidogrel/Aspirin 75/100
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about APX-Clopidogrel/Aspirin 75/100 intended for persons living in Australia.
  • Mayne Pharma Doxycycline
    Drug - 20 Jan 2023
    Consumer Medicine Information (CMI) about Mayne Pharma Doxycycline intended for persons living in Australia.
  • Doryx
    Drug - 20 Jan 2023
    Consumer Medicine Information (CMI) about Doryx intended for persons living in Australia.
  • Xalamol 50/5
    Drug - 17 Jan 2023
    Consumer Medicine Information (CMI) about Xalamol 50/5 (latanoprost and timolol) intended for persons living in Australia.
  • Perisyl Combi
    Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • LPV
    Drug - 15 Dec 2022
    Consumer Medicine Information (CMI) about LPV intended for persons living in Australia.
  • Pfizer Daptomycin
    Drug - 16 Nov 2022
    Consumer Medicine Information (CMI) about Pfizer Daptomycin intended for persons living in Australia.
  • Cuvitru
    Drug - 8 Nov 2022
    Consumer Medicine Information (CMI) about Cuvitru intended for persons living in Australia.
  • Adenuric tablets
    Drug - 7 Nov 2022
    Consumer Medicine Information (CMI) about Adenuric tablets intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback